| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiac Surgical Procedures | 13 | 2024 | 3683 | 2.020 |
Why?
|
| Extracorporeal Membrane Oxygenation | 8 | 2022 | 1481 | 1.110 |
Why?
|
| Nerve Block | 2 | 2024 | 717 | 0.990 |
Why?
|
| Postoperative Nausea and Vomiting | 1 | 2022 | 128 | 0.740 |
Why?
|
| Pain, Postoperative | 5 | 2024 | 1768 | 0.720 |
Why?
|
| Analgesics, Opioid | 3 | 2024 | 3837 | 0.580 |
Why?
|
| Shock, Septic | 1 | 2020 | 772 | 0.430 |
Why?
|
| Heart Defects, Congenital | 5 | 2022 | 4713 | 0.370 |
Why?
|
| Acute Kidney Injury | 2 | 2019 | 1946 | 0.330 |
Why?
|
| Catheterization | 2 | 2005 | 1430 | 0.310 |
Why?
|
| Extracorporeal Circulation | 1 | 2008 | 182 | 0.290 |
Why?
|
| Postoperative Complications | 5 | 2022 | 15824 | 0.250 |
Why?
|
| Umbilical Arteries | 1 | 2005 | 77 | 0.240 |
Why?
|
| Hypoplastic Left Heart Syndrome | 2 | 2008 | 595 | 0.240 |
Why?
|
| Nicotinic Agonists | 2 | 2018 | 265 | 0.240 |
Why?
|
| alpha-Fetoproteins | 1 | 2004 | 229 | 0.220 |
Why?
|
| Anesthetics, Intravenous | 1 | 2006 | 396 | 0.220 |
Why?
|
| Cardiotonic Agents | 1 | 2006 | 540 | 0.220 |
Why?
|
| Aortic Coarctation | 2 | 2003 | 278 | 0.220 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2006 | 483 | 0.210 |
Why?
|
| Morphine Derivatives | 1 | 2021 | 43 | 0.190 |
Why?
|
| Teratoma | 1 | 2004 | 405 | 0.190 |
Why?
|
| Propofol | 1 | 2006 | 608 | 0.180 |
Why?
|
| Heart Neoplasms | 1 | 2004 | 374 | 0.180 |
Why?
|
| Pericardium | 1 | 2004 | 681 | 0.170 |
Why?
|
| Dopamine | 1 | 2006 | 1581 | 0.160 |
Why?
|
| Aortic Rupture | 1 | 2002 | 322 | 0.160 |
Why?
|
| Retrospective Studies | 11 | 2024 | 81659 | 0.160 |
Why?
|
| Heart Block | 2 | 2011 | 391 | 0.160 |
Why?
|
| Child, Preschool | 5 | 2024 | 42606 | 0.160 |
Why?
|
| Lung Transplantation | 2 | 2018 | 1310 | 0.160 |
Why?
|
| Aortic Aneurysm, Thoracic | 1 | 2005 | 707 | 0.160 |
Why?
|
| Length of Stay | 3 | 2022 | 6489 | 0.150 |
Why?
|
| Myocytes, Cardiac | 2 | 2006 | 1672 | 0.150 |
Why?
|
| Furosemide | 1 | 2019 | 174 | 0.150 |
Why?
|
| Treatment Outcome | 10 | 2024 | 65295 | 0.140 |
Why?
|
| Hemofiltration | 1 | 2017 | 58 | 0.140 |
Why?
|
| Ethics Committees | 1 | 2016 | 51 | 0.140 |
Why?
|
| Genetic Engineering | 1 | 2022 | 935 | 0.130 |
Why?
|
| Employment | 1 | 2022 | 1110 | 0.130 |
Why?
|
| Takotsubo Cardiomyopathy | 1 | 2018 | 125 | 0.130 |
Why?
|
| Poisoning | 1 | 2017 | 253 | 0.130 |
Why?
|
| Pheochromocytoma | 1 | 2018 | 328 | 0.130 |
Why?
|
| Shock | 1 | 2018 | 316 | 0.130 |
Why?
|
| Goals | 1 | 2021 | 717 | 0.120 |
Why?
|
| Humans | 36 | 2024 | 767040 | 0.120 |
Why?
|
| Adrenal Glands | 1 | 2018 | 557 | 0.120 |
Why?
|
| Child | 7 | 2024 | 80771 | 0.120 |
Why?
|
| Survival Rate | 5 | 2021 | 12823 | 0.120 |
Why?
|
| Smoking Cessation | 2 | 2018 | 2085 | 0.120 |
Why?
|
| Pacemaker, Artificial | 2 | 2011 | 828 | 0.120 |
Why?
|
| Fat Emulsions, Intravenous | 1 | 2017 | 314 | 0.110 |
Why?
|
| Pulmonary Fibrosis | 1 | 2018 | 505 | 0.110 |
Why?
|
| Hemolysis | 1 | 2016 | 417 | 0.110 |
Why?
|
| Acute Coronary Syndrome | 2 | 2018 | 2193 | 0.110 |
Why?
|
| Apoptosis | 2 | 2006 | 9513 | 0.110 |
Why?
|
| Pain Measurement | 1 | 2024 | 3584 | 0.110 |
Why?
|
| Heart | 2 | 2022 | 4429 | 0.110 |
Why?
|
| Vascular Resistance | 1 | 2016 | 939 | 0.110 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2021 | 996 | 0.110 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2018 | 733 | 0.100 |
Why?
|
| Shock, Cardiogenic | 1 | 2018 | 709 | 0.100 |
Why?
|
| Neoplasm Proteins | 1 | 2004 | 3599 | 0.100 |
Why?
|
| Echocardiography, Transesophageal | 1 | 2018 | 1096 | 0.100 |
Why?
|
| Heart Arrest | 1 | 2021 | 1516 | 0.090 |
Why?
|
| Cardiopulmonary Bypass | 1 | 2016 | 1097 | 0.090 |
Why?
|
| Stents | 1 | 2002 | 3193 | 0.090 |
Why?
|
| Nitric Oxide | 1 | 2019 | 2140 | 0.090 |
Why?
|
| Prospective Studies | 4 | 2024 | 54886 | 0.090 |
Why?
|
| Cardiology | 1 | 2021 | 1701 | 0.080 |
Why?
|
| Specialties, Surgical | 1 | 2014 | 391 | 0.080 |
Why?
|
| Time Factors | 4 | 2024 | 40154 | 0.080 |
Why?
|
| Male | 17 | 2024 | 364203 | 0.080 |
Why?
|
| Female | 21 | 2024 | 396660 | 0.080 |
Why?
|
| Equipment Failure | 1 | 2011 | 585 | 0.080 |
Why?
|
| Myocardial Ischemia | 2 | 2011 | 2131 | 0.080 |
Why?
|
| Hemodynamics | 2 | 2017 | 4186 | 0.080 |
Why?
|
| Sheep | 1 | 2010 | 1449 | 0.070 |
Why?
|
| Aorta, Thoracic | 3 | 2010 | 1110 | 0.070 |
Why?
|
| Thrombosis | 1 | 2022 | 2954 | 0.070 |
Why?
|
| Pediatrics | 2 | 2021 | 3621 | 0.070 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2018 | 2144 | 0.070 |
Why?
|
| Hypertension, Pulmonary | 1 | 2018 | 1604 | 0.070 |
Why?
|
| Endothelium, Vascular | 1 | 2019 | 4424 | 0.070 |
Why?
|
| Pain | 1 | 2022 | 5101 | 0.070 |
Why?
|
| Cold Ischemia | 1 | 2006 | 72 | 0.070 |
Why?
|
| Device Removal | 1 | 2011 | 643 | 0.060 |
Why?
|
| Hospital Mortality | 1 | 2020 | 5345 | 0.060 |
Why?
|
| Blood Pressure | 2 | 2018 | 8531 | 0.060 |
Why?
|
| Muscle Cells | 1 | 2006 | 194 | 0.060 |
Why?
|
| Blood Vessel Prosthesis Implantation | 3 | 2005 | 1456 | 0.060 |
Why?
|
| Patient Readmission | 1 | 2019 | 3283 | 0.060 |
Why?
|
| Ventricular Function, Left | 1 | 2018 | 3934 | 0.060 |
Why?
|
| Perfusion | 1 | 2010 | 1409 | 0.060 |
Why?
|
| Myocardium | 1 | 2018 | 4765 | 0.060 |
Why?
|
| Quality Indicators, Health Care | 1 | 2014 | 1804 | 0.060 |
Why?
|
| Pulmonary Embolism | 1 | 2017 | 2598 | 0.060 |
Why?
|
| Abdomen | 1 | 2010 | 1138 | 0.060 |
Why?
|
| Quality Assurance, Health Care | 1 | 2014 | 2174 | 0.060 |
Why?
|
| Adolescent | 2 | 2024 | 89046 | 0.060 |
Why?
|
| Electrocoagulation | 1 | 2004 | 156 | 0.060 |
Why?
|
| Recovery of Function | 2 | 2021 | 2978 | 0.060 |
Why?
|
| Rabbits | 2 | 2006 | 4751 | 0.050 |
Why?
|
| Brachiocephalic Veins | 1 | 2003 | 21 | 0.050 |
Why?
|
| Referral and Consultation | 1 | 2016 | 3618 | 0.050 |
Why?
|
| Middle Aged | 12 | 2020 | 223233 | 0.050 |
Why?
|
| Surgical Procedures, Operative | 1 | 2014 | 1931 | 0.050 |
Why?
|
| Phenoxybenzamine | 1 | 2002 | 53 | 0.050 |
Why?
|
| Emergencies | 2 | 2011 | 1223 | 0.050 |
Why?
|
| Vascular Surgical Procedures | 1 | 2010 | 1506 | 0.050 |
Why?
|
| Infant | 2 | 2022 | 36485 | 0.050 |
Why?
|
| Adult | 9 | 2022 | 223317 | 0.050 |
Why?
|
| Smoking | 1 | 2018 | 9081 | 0.050 |
Why?
|
| Myocardial Contraction | 1 | 2006 | 1516 | 0.050 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2006 | 856 | 0.050 |
Why?
|
| Heart Conduction System | 1 | 2006 | 1008 | 0.040 |
Why?
|
| Aortography | 1 | 2002 | 423 | 0.040 |
Why?
|
| Vasopressins | 1 | 2002 | 358 | 0.040 |
Why?
|
| Infant, Low Birth Weight | 1 | 2005 | 871 | 0.040 |
Why?
|
| Models, Animal | 1 | 2006 | 2121 | 0.040 |
Why?
|
| Cerebrovascular Circulation | 1 | 2010 | 2672 | 0.040 |
Why?
|
| Endothelium-Dependent Relaxing Factors | 1 | 2019 | 21 | 0.040 |
Why?
|
| Thorax | 1 | 2022 | 556 | 0.040 |
Why?
|
| Incidental Findings | 1 | 2004 | 698 | 0.040 |
Why?
|
| Infant, Newborn | 5 | 2010 | 26396 | 0.040 |
Why?
|
| Kidney Diseases | 1 | 2010 | 2099 | 0.040 |
Why?
|
| United States | 4 | 2020 | 72971 | 0.040 |
Why?
|
| Atrioventricular Node | 2 | 2010 | 180 | 0.040 |
Why?
|
| Femoral Artery | 1 | 2022 | 827 | 0.040 |
Why?
|
| Animals, Genetically Modified | 1 | 2022 | 1562 | 0.040 |
Why?
|
| Primary Graft Dysfunction | 1 | 2018 | 112 | 0.040 |
Why?
|
| Alprazolam | 1 | 2017 | 103 | 0.040 |
Why?
|
| Graft Rejection | 2 | 2022 | 4498 | 0.030 |
Why?
|
| Erythrocyte Transfusion | 1 | 2022 | 575 | 0.030 |
Why?
|
| Diltiazem | 1 | 2017 | 132 | 0.030 |
Why?
|
| Delphi Technique | 1 | 2021 | 891 | 0.030 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2006 | 1337 | 0.030 |
Why?
|
| Antidotes | 1 | 2017 | 138 | 0.030 |
Why?
|
| Tissue Engineering | 1 | 2006 | 1861 | 0.030 |
Why?
|
| Digoxin | 1 | 2017 | 246 | 0.030 |
Why?
|
| Administration, Inhalation | 1 | 2019 | 1154 | 0.030 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2004 | 1772 | 0.030 |
Why?
|
| Hypotension | 1 | 2002 | 888 | 0.030 |
Why?
|
| Hospitalization | 1 | 2015 | 10815 | 0.030 |
Why?
|
| Infant, Premature | 1 | 2005 | 2125 | 0.030 |
Why?
|
| Blood Transfusion | 1 | 2022 | 1308 | 0.030 |
Why?
|
| Cesarean Section | 1 | 2004 | 1419 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2006 | 3511 | 0.030 |
Why?
|
| Gestational Age | 1 | 2004 | 3618 | 0.030 |
Why?
|
| Brain Death | 1 | 2018 | 360 | 0.030 |
Why?
|
| Multiple Organ Failure | 1 | 2017 | 389 | 0.030 |
Why?
|
| Transplantation, Heterologous | 1 | 2022 | 2391 | 0.030 |
Why?
|
| Troponin I | 1 | 2018 | 659 | 0.030 |
Why?
|
| Age Factors | 2 | 2021 | 18401 | 0.030 |
Why?
|
| Heart Transplantation | 1 | 2006 | 3305 | 0.030 |
Why?
|
| Double-Blind Method | 2 | 2018 | 12451 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2017 | 1836 | 0.030 |
Why?
|
| Canada | 1 | 2018 | 2127 | 0.030 |
Why?
|
| Electrocardiography | 2 | 2018 | 6409 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2010 | 18330 | 0.020 |
Why?
|
| Follow-Up Studies | 4 | 2018 | 39317 | 0.020 |
Why?
|
| Consensus | 1 | 2021 | 3207 | 0.020 |
Why?
|
| Muscle, Skeletal | 1 | 2006 | 4968 | 0.020 |
Why?
|
| Bundle of His | 1 | 2010 | 102 | 0.020 |
Why?
|
| Cohort Studies | 3 | 2018 | 41718 | 0.020 |
Why?
|
| Tissue and Organ Procurement | 1 | 2018 | 987 | 0.020 |
Why?
|
| Risk Assessment | 4 | 2018 | 24299 | 0.020 |
Why?
|
| Echocardiography | 2 | 2018 | 5042 | 0.020 |
Why?
|
| Critical Care | 1 | 2022 | 2714 | 0.020 |
Why?
|
| Thoracotomy | 1 | 2011 | 374 | 0.020 |
Why?
|
| Evidence-Based Medicine | 1 | 2021 | 3700 | 0.020 |
Why?
|
| Animals | 5 | 2022 | 168965 | 0.020 |
Why?
|
| Aged | 5 | 2018 | 171319 | 0.020 |
Why?
|
| Prognosis | 2 | 2019 | 29963 | 0.020 |
Why?
|
| Body Size | 1 | 2010 | 462 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2018 | 6513 | 0.020 |
Why?
|
| Graft Survival | 1 | 2018 | 3896 | 0.020 |
Why?
|
| Heart-Assist Devices | 1 | 2018 | 1287 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2019 | 10748 | 0.020 |
Why?
|
| Echocardiography, Doppler | 1 | 2011 | 898 | 0.020 |
Why?
|
| Cardiac Pacing, Artificial | 1 | 2011 | 881 | 0.020 |
Why?
|
| Anti-Bacterial Agents | 1 | 2005 | 7469 | 0.020 |
Why?
|
| Regional Blood Flow | 1 | 2010 | 1479 | 0.020 |
Why?
|
| Electrodes, Implanted | 1 | 2011 | 835 | 0.020 |
Why?
|
| Prosthesis Implantation | 1 | 2010 | 594 | 0.020 |
Why?
|
| Coronary Angiography | 1 | 2018 | 4525 | 0.020 |
Why?
|
| Academic Medical Centers | 1 | 2016 | 2783 | 0.020 |
Why?
|
| Risk | 1 | 2017 | 9606 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2018 | 10092 | 0.020 |
Why?
|
| Ligation | 1 | 2006 | 446 | 0.020 |
Why?
|
| Rare Diseases | 1 | 2011 | 630 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2006 | 610 | 0.020 |
Why?
|
| Patient Participation | 1 | 2014 | 1444 | 0.020 |
Why?
|
| Connexins | 1 | 2006 | 355 | 0.010 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2006 | 685 | 0.010 |
Why?
|
| Rats, Inbred Lew | 1 | 2006 | 1168 | 0.010 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2006 | 428 | 0.010 |
Why?
|
| Cell Transplantation | 1 | 2006 | 475 | 0.010 |
Why?
|
| Patient-Centered Care | 1 | 2014 | 1444 | 0.010 |
Why?
|
| Stroke Volume | 1 | 2018 | 5618 | 0.010 |
Why?
|
| Aortic Stenosis, Subvalvular | 1 | 2003 | 10 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2006 | 1647 | 0.010 |
Why?
|
| Capillaries | 1 | 2006 | 755 | 0.010 |
Why?
|
| Intensive Care Units | 1 | 2016 | 3797 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2018 | 12986 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2018 | 8068 | 0.010 |
Why?
|
| Pregnancy | 1 | 2004 | 30238 | 0.010 |
Why?
|
| Societies, Medical | 1 | 2014 | 3964 | 0.010 |
Why?
|
| Heart Function Tests | 1 | 2002 | 316 | 0.010 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2006 | 1331 | 0.010 |
Why?
|
| Aortic Valve | 1 | 2010 | 1968 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 2006 | 2677 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2006 | 2509 | 0.010 |
Why?
|
| Heart Septal Defects, Ventricular | 1 | 2003 | 477 | 0.010 |
Why?
|
| Acute Disease | 1 | 2010 | 7236 | 0.010 |
Why?
|
| Anastomosis, Surgical | 1 | 2003 | 992 | 0.010 |
Why?
|
| Neovascularization, Physiologic | 1 | 2006 | 1368 | 0.010 |
Why?
|
| Cell Communication | 1 | 2006 | 1660 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2002 | 20741 | 0.010 |
Why?
|
| Catheter Ablation | 1 | 2010 | 2787 | 0.010 |
Why?
|
| Postoperative Period | 1 | 2002 | 1824 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2006 | 6067 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2006 | 6507 | 0.010 |
Why?
|
| Stem Cells | 1 | 2006 | 3535 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 11063 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 59548 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2010 | 22254 | 0.010 |
Why?
|
| Incidence | 1 | 2010 | 21526 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2018 | 36582 | 0.010 |
Why?
|
| Rats | 1 | 2006 | 23713 | 0.010 |
Why?
|
| Disease Progression | 1 | 2006 | 13646 | 0.000 |
Why?
|
| Cell Differentiation | 1 | 2006 | 11657 | 0.000 |
Why?
|
| Risk Factors | 1 | 2010 | 74886 | 0.000 |
Why?
|